文献速递药物相互作用治疗药物监测与药物基因组学

美他唑诱导伏立康唑代谢并导致亚治疗浓度

Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations.
PubMed 文献 · Br J Clin Pharmacol · 2025-04-27

该单中心回顾性观察队列研究纳入9例患者,比较美他唑治疗前、中、后伏立康唑血清谷浓度。建议避免联用或密切监测伏立康唑谷浓度。

要点

  • 美他唑治疗期间伏立康唑谷浓度中位数下降71%。
  • 联用美他唑时亚治疗伏立康唑浓度发生率为70%。
  • 建议避免联用,或监测伏立康唑谷浓度至美他唑停药后2周。

核心结论

  • 美他唑通过诱导CYP3A4和CYP2C19增加伏立康唑代谢,降低伏立康唑谷浓度。
  • 建议避免美他唑与伏立康唑联用,或在美他唑治疗期间及停药后2周内密切监测伏立康唑谷浓度。

研究设计与样本

  • 单中心回顾性观察队列研究,纳入9例患者,比较美他唑治疗前、中、后的伏立康唑血清谷浓度。

主要发现

  • 亚治疗伏立康唑谷浓度在美他唑治疗前为14%、治疗期间为70%、治疗后为17%。

临床怎么用

  • 临床应避免美他唑与伏立康唑联用。
  • 若必须联用,应在美他唑治疗期间及停药后2周内密切监测伏立康唑谷浓度。

局限性

  • 本研究为单中心回顾性观察性研究,样本量仅9例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Voriconazole is extensively metabolized via cytochrome P450 (CYP) enzymes, predominantly CYP2C19 and CYP3A4. Drugs influencing the activity or expression of CYP enzymes can cause clinically relevant changes in the metabolism and voriconazole exposure. Metamizole is known to induce CYP3A4 and CYP2C19. This study aimed to investigate the pharmacokinetic drug-drug interaction between metamizole and voriconazole. METHODS: In this single-centre retrospective observational cohort study, we compared voriconazole serum trough concentrations before, during and after metamizole treatment. RESULTS: In the 9 included patients, the median voriconazole trough concentration decreased by 71% during metamizole treatment (P = .028) compared to before start of metamizole. The concentration/dose ratio similarly decreased by 81% during metamizole treatment (P = .018). Additionally, the metabolic ratio (voriconazole-n-oxide/voriconazole) increased from 0.9 to 2.4 (P = .028) during metamizole treatment. Subtherapeutic voriconazole trough concentrations were more frequent when combined with metamizole (before 14%, during 70%, after 17%). CONCLUSIONS: Metamizole increases voriconazole metabolism and decreases voriconazole trough concentrations, probably through a CYP3A4 and CYP2C19 inducing effect. It is recommended to avoid concurrent use of metamizole and voriconazole or to closely monitor voriconazole trough concentrations during metamizole treatment and up to 2 weeks after discontinuation of metamizole.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Baan SD, Touw DJ, Lub-de Hooge MN, et al. Metamizole induces voriconazole metabolism and results in subtherapeutic voriconazole concentrations. Br J Clin Pharmacol. 2025. PMID: 40289271. doi:10.1002/bcp.70079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。